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ABSTRACT
The present review presents basic concepts of blood rheology related to vascular diseases. Blood flow in large arteries is 
dominated by inertial forces exhibited at high flow velocities, while viscous forces (i.e., blood rheology) play an almost negli-
gible role. When high flow velocity is compromised by sudden deceleration as at a bifurcation, endothelial cell dysfunction 
can occur along the outer wall of the bifurcation, initiating inflammatory gene expression and, through mechanotransduc-
tion, the cascade of events associated with atherosclerosis. In sharp contrast, the flow of blood in microvessels is dominated 
by viscous shear forces since the inertial forces are negligible due to low flow velocities. Shear stress is a critical parameter in 
microvascular flow, and a force-balance approach is proposed for determining microvascular shear stress, accounting for 
the low Reynolds numbers and the dominance of viscous forces over inertial forces. Accordingly, when the attractive forces 
between erythrocytes (represented by the yield stress of blood) are greater than the shear force produced by microvascular 
flow, tissue perfusion itself cannot be sustained, leading to capillary loss. The yield stress parameter is presented as a diag-
nostic candidate for future clinical research, specifically, as a fluid dynamic biomarker for microvascular disorders. The rela-
tion between the yield stress and diastolic blood viscosity (DBV) is described using the Casson model for viscosity, from 
which one may be able determine thresholds of DBV where the risk of microvascular disorders is high. (Korean Circ J 
2011;41:287-295)
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Introduction
Atherosclerosis and microvascular disorders are two con-
trasting manifestations of pathophysiologic blood flow. The 
flow in large arteries is characterized by higher velocities of 
10-70 cm/s at peak systole.
1-4) Since both flow velocity and 
lumen diameter vary greatly throughout the systemic circu-
lation, a dimensionless number called the Reynolds number 
can be used to describe the hemodynamic character of vas-
cular flow. It is defined as ρVd/μ, where ρ and μ are the den-
sity and viscosity of blood, respectively, V is flow velocity, 
and d is lumen diameter. The Reynolds number represents 
the ratio of inertial forces (i.e., kinetic energy) to the viscous 
forces in flow. For example, the Reynolds number corre-
sponding to large-arterial flow is in the range of 100-850.
5) In 
other words, the inertial forces are 100-850 times greater than 
the viscous forces primarily in such a flow regime due to the 
higher flow velocity. 
The microvascular network is far more intricate than the 
large arteries and is crowded with a number of branches and 
anastomoses in a small space. In arteriole flow, the corresp-
onding Reynolds number is on the order of 0.0006 due to lo-
wer flow velocities and smaller diameters, indicating that the 
viscous forces are about 1,600 times greater than the inertial 
forces in the arteriole regimes.
5) For capillary flow, the corre-
sponding Reynolds number is approximately 0.001-0.0005 
with a flow velocity in a range of 0.05-0.1 cm/s.
1-4) At capilla-
ries, hematocrit levels have been reported to be as much as 
21% lower than systemic hematocrit levels (33±7% vs. 42± 
6%, respectively).
6) Not only is hematocrit reduced at the cap-
illaries, but viscosity levels are also lower at capillaries relative 
to systemic viscosity because of the Fähraeus-Lindqvist wall 
effect at the capillary.
1)7) Despite these factors, the Reynolds 
number still holds an order of magnitude of 0.001 at the 288   Hemorheology and Microvascular Disorders 
capillaries, indicating that viscous forces are about 1,000 times 
greater than inertial forces. 
In consideration of the fluid mechanical framework above, 
it is helpful and altogether correct to postulate that blood flow 
in the microvasculature is essentially determined by viscous 
forces, i.e., the viscosity of blood. The objective of the present 
paper was to provide an in-depth review of how the rheolo-
gical properties of blood affect microvascular flows. The pre-
sent paper underscores yield stress as the key rheological pro-
perty of blood which modulates the microvascular flow. 
Furthermore, the paper discusses how whole blood viscosity 
(WBV) is related to the yield stress and proposes a frame-
work for establishing critical thresholds for pathophysiologic 
diastolic blood viscosity (DBV) levels which may trigger the 
onset of microvascular disorders. 
Hemorheology
Hemorheology is the study of blood flow in a vessel with an 
emphasis on the behavior of the erythrocytes as they inter-
act and as quantifiable biophysical patterns emerge from the 
interactions of erythrocytes in the vascular system. As whole 
blood consists of cells and plasma, the blood is a vigorous or-
gan and behaves as a non-Newtonian fluid, where the fluid 
viscosity varies with shear rate.
2-4)8) Note that the shear rate re-
presents the ratio of fluid velocity to lumen diameter. The 
main reason why whole blood exhibits non-Newtonian visco-
sity is due to the presence and interaction of blood cells. In 
many engineering fluids containing micron-size solid parti-
cles (such as paints), the maximum concentration of suspend-
ed particles is about 50%; beyond this concentration, the fluid-
mixture stops flowing due to its high viscosity.
9) In contrast, 
whole blood flows relatively easily through blood vessels even 
at erythrocyte concentrations much higher than 50% because 
of the flexible membrane of erythrocytes.
9) Hence, any condi-
tion that alters normal erythrocyte physiology can have a ma-
jor adverse impact on blood flow. 
Blood viscosity is the inherent resistance of blood to flow 
and represents the thickness and stickiness of blood. The blo-
od becomes stickier when it moves slowly during diastole, 
whereas it becomes thinner when blood moves quickly dur-
ing systole, a phenomenon which is described as the shear-
thinning, non-Newtonian behavior of whole blood.
8)10)11) Blo-
od viscosity represents a dynamic property of blood, whereas 
hematocrit, lipid profiles, glucose, creatinine, plasma prot-
eins, osmolality, among others, represent static properties of 
blood. The dynamic range of WBV is relatively large, i.e., 40-
450 mP,
8)10)11) which highlights the potential utility of this pa-
rameter as a biomarker-to the degree that viscosity provides 
additional incremental prediction of clinical outcomes and 
is modifiable by therapeutic modalities. 
The viscosity of a fluid represents the friction between a 
moving fluid and stationary wall. Left-ventricular motion of 
the heart provides the blood pressure necessary to overcome 
the friction exerted by moving blood on arterial walls. As such, 
all other conditions held equal, a relative increase in WBV for 
a given patient will, by necessity, represent an increased bur-
den of work to the heart. 
Due to the non-Newtonian characteristics of blood, its vis-
cosity varies greatly with time during a cardiac cycle. In ad-
dition, WBV varies with the anatomical configuration of an 
artery. For example, the diameter of the coronary artery is ab-
out 3 mm, whereas that of the aorta is approximately 2.5 cm.
2-4) 
Thus, the WBV at the coronary artery is different from that at 
the aorta because of different shear rates at the two locations. 
Shear rate γ
. is defined as ~8V/d, where V is flow velocity and 
d is lumen diameter. As blood passes through a bifurcation, 
blood decelerates along the outer wall of the bifurcation, gr-
eatly reducing the local shear rate at the outer wall. This causes 
WBV at the outer wall of the bifurcation (i.e., a low-shear-rate 
area) to be much greater than that at the wall of the main lu-
men (i.e., a high-shear-rate area), a phenomenon which can 
cause endothelial dysfunction and is described in greater 
detail below.
12) 
When blood moves through large arteries, blood viscosity 
profiles are decreased relative to other segments of the vascul-
ature, i.e., blood becomes thinner as erythrocytes are fully dis-
persed due to higher flow velocity in large arteries. Blood vis-
cosity values corresponding to the high flow velocity is de-
fined as the systolic blood viscosity (SBV), analogous to sys-
tolic blood pressure. SBV is measured at a shear rate of 300 s
-1 
and has a normal value of about 3.8 cP (38 mP) (Fig. 1).
3)8)10)11)13-19) 
A small increase in SBV will not affect the overall flow in the 
large arteries, since the viscous forces are almost negligible 
compared with the inertial forces in the large arteries
2-4) as 
mentioned above. 
The DBV is the viscosity corresponding to low flow veloci-
Hct 45% (75 kg)
Hct 45% (73 kg)
Normal
Fig. 1. Whole blood viscosity curves for two apparently healthy 
subjects with Hct of 45%. Normal blood viscosity is given in solid 
line with closed triangular symbols. 1 cP=10 mP. WBV: whole 
blood viscosity, RBC: red blood cell.
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ty as experienced in microcirculation. This is the viscosity of 
blood measured at a low shear rate of 5 s
-1 or less. In patients 
presenting with essential hypertension,
20) myocardial infarc-
tion,
20)21) ischemic stroke,
22)23) or PAD,
24) the DBV levels have 
been observed to be higher than that of healthy controls. The 
DBV in normal human subjects is about 20 cP (200 mP) at a 
shear rate of 1 s
-1 (Fig. 1),
3)8)10)11)13-19) which is about five times 
greater than the SBV. One of the reasons why DBV is much gr-
eater than SBV is that erythrocyte aggregation occurs when 
blood moves very slowly in a small vessel. Both fibrinogen 
and low density lipoprotein-cholesterol (LDL-C) molecules 
promote erythrocyte aggregation.
10)25) Fibrinogen is a long 
chain molecule with length of approximately 47-48 nm and 
molecular weight of 340,000 daltons and adheres to the mem-
brane surface of erythrocytes.
26)27) As erythrocytes at lower 
shear rates cluster and crowd together, fibrinogen molecules 
form a cross-linking network structure, encouraging eryth-
rocyte aggregation.
10)11)28)29) 
The erythrocyte surface has about 200 binding sites for LDL- 
C or high density lipoprotein-cholesterol (HDL-C) molecu-
les.
30) The distance between two aggregated erythrocytes is 
about 19 nm due to red blood cell electrostatic repulsion. In or-
der for erythrocytes to aggregate, a bridging molecule with a 
diameter greater than 19 nm should simultaneously bind to 
two erythrocytes.
30) Since LDL-C molecules have diameters of 
18-30 nm, they can bind to two adjacent erythrocytes, thus 
promoting the aggregation, encouraging rouleaux formation 
of erythrocytes,
31) which directly increases DBV. In contrast, 
the size of HDL-C is only 5-12 nm so that it is too small to si-
multaneously bind to two erythrocytes.
25) When HDL-C bind 
to these binding sites, the binding sites are not available for 
LDL-C. Acting in this way, HDL-C suppresses erythrocyte ag-
gregation and accordingly reduces DBV.
30)31) In addition, LDL-C 
molecules can decrease erythrocyte deformability by increasing 
the cholesterol-to-phospholipid ratio at the erythrocyte mem-
brane,
30) resulting in the increased SBV. Glucose, osmolality, and 
dehydration all adversely affect the erythrocyte membrane, mak-
ing the membrane stiff, and thus increasing the blood viscosity. 
Fig. 1 shows a normal blood viscosity curve (see triangu-
lar symbols)
3)8)10)11)13-19) together with two blood viscosity cur-
ves (see two open symbols) obtained from two apparently he-
althy male adults both with hematocrit of 45%. These two 
isolated cases are shown here to highlight the dynamic range 
of blood viscosity profiles and their biochemical and cellular 
determinants. The high shear blood viscosities were relative-
ly similar in the two cases, whereas a large difference was 
observed in the low shear blood viscosities. The two most 
important parameters that influence the blood viscosity pro-
file are hematocrit (Hct) and plasma proteins (i.e., fibrinogen); 
lipid profiles such as LDL-C, HDL-C and triglyceride also 
affect low-shear blood viscosity more poignantly than high-
shear viscosity.
10) 
Hematocrit is the volume fraction of erythrocytes in whole 
blood. As the Hct increases, the friction will increase between 
moving blood and the arterial wall, resulting in an elevated 
WBV. A paradigmatic example is the clinical entity of poly-
cythemia vera, where hematocrit can be 60-65% or greater.
10) 
At such high Hct, WBV increases exponentially with Hct. The 
relationship between the hematocrit and SBV was described 
by Hall
32) and can be expressed by the following equation:
33)
SBV [cP]=1.4175+5.878 H-12.98 H
2+31.964 H
3  (1)
where H is given as the volume fraction, i.e., % divided by 100.
Oxygen Delivery Index
Since the red cells carry hemoglobin molecules, one may 
think that the higher the hematocrit, the more oxygen that 
the whole blood can deliver. Indeed, this is a sensible line of 
reasoning which has been the basis of several large random-
ized controlled studies of erythropoietin as a therapeutic 
modality for reducing cardiovascular outcomes for patients 
with kidney insufficiency.
34-37) However from a hemodyna-
mic perspective, elevated hematocrit can increase the fric-
tion of the whole blood and actually reduce the ability of blo-
od to transport hemoglobin. Therefore, in order to quantify 
this delicate balance, hemorheologists have developed a pa-
rameter known as the oxygen delivery index (ODI), which 
is calculated as the ratio between the hematocrit and SBV.
38)
ODI=
Hematocrit
=
100H
(2)
SBV 1.4175+5.878-12.98H
2+31.964H
3
where H is the volume fraction of erythrocytes. 
Fig. 2 shows the ODI curve vs. Hct calculated using Hall’s 
SBV data which is superimposed in the figure.
32) In this parti-
cular case, the optimum ODI occurs in a range of Hct of 0.37- 
Fig. 2. Oxygen delivery index (ODI) vs. hematocrit calculated using 
“systolic” blood viscosity (SBV) data given in Hall,
32) valid for flows 
in large arteries. 1 cP=10 mP.
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0.38, which is significantly less than the conventional values 
for normal Hct, especially for males (i.e., male: 0.4-0.54; fe-
male: 0.37-0.47). The reason why the optimum ODI occurs 
at Hct lower than the established normal values is due to the 
exponential increase in SBV with increasing Hct. This was 
confirmed by Usami et al.
39) who similarly found that the 
Hct level for optimal hemoglobin transport was 0.38 for hu-
mans, using WBV data obtained at a shear rate of 52 s
-1. Note 
that the optimum Hct of 0.38 is only valid for flow in large 
arteries, where the flow velocity of blood is large enough to 
uniformly disperse erythrocytes. In this regard, Alexy et al.
40) 
reported that in a low-shear-rate flow where the flow veloci-
ty is relatively very small, the ODI linearly decreased with the 
Hct. In other words, for microvascular flow regimes, the 
smaller the Hct, the more efficiently the oxygen can be tr-
ansported. Kenyeres et al.
41) performed Kaplan-Meier sur-
vival analysis on the impact of the ODI on cardiac mortality 
(p=0.009), stating that the ODI showed significant negative 
correlation with the frequency of hospital admissions (r= 
-0.377, p=0.03) and low ODI could be regarded as a risk fac-
tor of cardiac death in coronary heart disease.
Shear Stress
Stress is defined as the force per unit area, and the hemo-
dynamic wall shear stress, also called vascular shear stress or 
endothelial shear stress, represents the frictional shear force 
exerted by moving blood upon unit area of arterial wall. The 
adjective “shear” means frictional or tangential. Mathemati-
cally, the shear stress τ is defined as the product of fluid visco-
sity μ and shear rate γ
. as described by the following equa-
tion:
3-5)11)
τ=μ . γ
.  (3)
In a straight segment of a large artery, where blood moves at 
a high velocity, the wall shear stress has a value of 15-70 dyne/ 
cm
2 under normal physiological conditions.
2)4)12) Endothelial 
cells respond positively to normal physiologic shear stress by 
remaining in their elongated phalanx formation, generating 
endothelial NO synthase (eNOS) mRNA and atheroprotec-
tive gene expression, but decreasing endothelin-1 (ET-1) mes-
senger ribonucleic acid (mRNA).
12)42)
With decelerated flows-acute or chronic, the blood recircu-
lates and oscillates at the outer wall of bifurcations. Vascular 
shear stresses at the outer wall then periodically change from 
normal physiologic levels to low pathophysiologic levels, i.e., 
≤4 dyne/cm
12)43) Endothelial cells exposed to low vascular sh-
ear stresses lose their elongated phalanx formation and adopt 
a rounder profile, negatively responding to oscillatory low sh-
ear stresses by favoring the uptake of oxidized LDL-C, up-
regulating ICAM-1, VCAM-1, MCP-1, E-selectin, TNFα, bone 
morphogenic protein-4 (BMP-4), while decreasing eNOS 
mRNA and protein expression.
12)42)43) Throughout the litera-
ture, pathophysiologic low shear stresses are associated with 
augmented expression of inflammatory genes responsible for 
increased synthesis of endothelial-localized adhesion mole-
cules, transmigration of mononuclear cells into subendothe-
lial space, and intrusion and incorporation of lipoproteins 
into tissue macrophages.
44-49)
Shear Rate
Shear rate γ
. is defined as the velocity gradient, dV/dr, which 
represents the ratio of the blood flow velocity V to lumen dia-
meter d. For a Newtonian fluid, it can be expressed by the 
following equation:
2)5)10) 
γ
.=8
V (4)
d
For a non-Newtonian fluid such as blood, the constant is 
slightly greater than 8.
10)33) The shear rate in a large artery is in 
the range of 100-2,000 s
-1 during systole.
2)4)10) As the shear rate 
increases above 300 s
-1, WBV decreases to a minimum asy-
mptotic value because the erythrocytes are uniformly dis-
persed by high blood velocity. At the minimum asymptote, a 
Newtonian viscosity of 3.8 cP (38 mP) is obtained in normal 
subjects (Fig. 1); this value can be used for the wall shear 
stress calculation for the flow in the large artery as the first 
approximation.
For the flow regimes in both arterioles and capillaries, the 
corresponding shear rates are also in the high range of 400-
1,600 s
-1 which is due to relatively small lumen diameters (i.e., 
less than 60 μm).
4)6)50) In contrast to these high shear rates, the 
flow velocities are rather small (i.e., less than 0.1 cm/s) such 
that the erythrocytes cannot be uniformly dispersed, and the 
conditions that produced the minimum asymptotic blood vis-
cosity cannot be attained at the high shear rates. Instead, ery-
throcytes tend to aggregate, critically affecting the flow at 
the microvascular network. 
In careful consideration of the above, the shear rate para-
meter alone should not be used to estimate the shear stress 
for microvascular flows. How then shall we estimate the shear 
stress in the flow regimes of microvascular network?
Yield Stress 
The maintenance of the perfusion at small vessels such as 
capillaries is one of the most important challenges in the 
treatment of microvascular diseases. For example, diabetic 
retinopathy, nephropathy, and neuropathy are known for the 
poor perfusion at small microvessels, leading to capillary loss. 
These complications related to diabetes are included among 
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crovascular disorders. Similar phenomena occur in other cli-
nical entities such as hypertension and chronic renal failure, 
where the capillary density at myocardium has been report-
ed to be significantly lower than that of normal subjects.
51) In 
order to appreciate the cause of capillary loss in such cases, 
one can examine the forces involved in the flow at the capil-
lary vessels. 
A rheological property of blood particularly useful for the 
study of microvascular flow is the yield stress, τy. Homoge-
neous fluids which do not have suspended particles such as 
water or plasma do not have the yield stress, whereas fluids 
with suspended particles do have the yield stress. The yield 
stress can be defined as the limit of the shear stress when the 
shear rate approaches zero. Merrill and his co-workers de-
scribed the yield stress as the minimum shear stress required 
to maintain the blood in continuous flow.
52) Blood can appro-
ach a standstill in living circulation such as in post-capillary 
vessels with the occurrence of stasis or cessation of blood 
flow.
53) The physical origin of the yield stress is the attractive 
forces (i.e., ion bridges, hydrogen bonds, electrostatic charg-
es and van der Waals forces) among the particles suspended 
in a continuous medium, which permit rapid locking of the 
particles into three-dimensional networks.
54) Hence, in order 
to have a continuous flow, the shear stress produced by the 
flow (or pressure) should exceed the yield stress.
54) 
Copley and King pioneered the first measurement of the 
yield stress of blood at a shear rate of 0.0009 s
-1 with a Weis-
senberg rheogoniometer.
53) The yield stress at Hct of 40% for 
normal blood at 37°C varies in a range of 0.01-0.06 dyne/
cm
2.
33)54-56) Picart et al.
57) reported that the yield stress for 
normal blood was in a range of 0.05 to 0.06 dyne/cm
2 for Hct 
of 60%, and 0.2 to 0.25 dyne/cm
2 for Hct above 80%. There 
are several correlations which predict the yield stress of whole 
blood. Merrill and his co-workers
52)58) proposed a correlation:
τy=A[H-Hc]
3  (5)
where the constant A of 0.6-1.2 represents fibrinogen con-
centration, the limiting hematocrit Hc given as a volume frac-
tion is between 0.04 and 0.08, H is in a range of 0.3 and 0.5, 
and τy is in dyne/cm
2. From this correlation, they reported 
that the typical yield stress for normal blood at Hct of 0.4 was 
0.04 dyne/cm
2. Zydney et al.
59) proposed a correlation:
τy=0.71[H-0.05]
3  (6)
which gives the yield stress of 0.045 dyne/cm
2 at Hct of 0.45. 
Picart et al.
60) later proposed a correlation using the viscosity 
results of Chien et al.
61) which gives the yield stress of 0.025 
dyne/cm
2 at Hct of 0.45:
τy=0.27Hct
3  (7)
For polycythemia, Errill
58) reported a yield stress of 0.183 dyne/ 
cm
2 at Hct of 59.5%. Morris et al.
62) reported that the yield st-
ress increased at an accelerating rate in a range of Hct >60-
65% for normal blood, reaching 0.25 dyne/cm
2 at Hct of 80%. 
For systemic sclerosis, which is a typical microvascular abnor-
mality, the yield stress was significantly greater than normal 
subjects (+56%, p<0.05 at Hct of 60%).
63)
Shear Stress in Microvascular Flows 
Fig. 3A depicts uniformly dispersed erythrocytes experi-
encing high velocity flow in a large artery. For flow in a capill-
ary, erythrocytes tend to aggregate due to the attractive forc-
es among the erythrocytes as depicted in Fig. 3B. When the 
attractive forces are greater than the shear forces (i.e., dispers-
ing forces) created by the flow itself, hemostasis can occur 
locally due to the rapid interlocking of cells.
54)58) Subsequently, 
capillary loss, one of the most common features of microvas-
cular abnormalities, can occur. 
As mentioned previously, the shear stress should not be es-
timated by τ=μγ
. for microvascular flows, where viscous for-
ces, not inertial forces, control the flow. Instead, the micro-
vascular shear stress can be estimated by the following force 
balance equation:
τw=    ΔP . d
  (8)
              4L
Fig. 3. Sketch depicting uniformly dispersed erythrocytes for flow at a large artery (A), and erythrocytes locked when attractive forces are 
larger than shear forces produced by blood flow at capillary (B).
Blood flow at a large artery
Uniformly dispersed erythrocytes
Attractive forces among erythrocytes,
leading to rapid locking
Blood flow
Blood flow
Blood flow at capillary
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where d and L are the diameter and length of a microvessel, 
respectively, and ΔP is the pressure difference across the cap-
illary.
5) In other words, the shear stress at a microvascular 
network should be determined without using either flow ve-
locity and blood rheology. In normal physiology, the shear 
stress is much greater than the yield stress so that the perfusion 
at the microvascular network can be properly maintained. 
However, when the yield stress increases due to hyperviscos-
ity such that the attractive forces among cells result in their 
rapid interlocking, local microvascular flow can be acutely im-
paired, resulting in capillary loss. It is intended that this force 
balance equation for microvascular shear stress can serve as a 
cornerstone of a framework for developing and establishing 
fluid dynamic biomarkers that are predictive of microvascu-
lar disease complications. 
Capillary Network and Determination 
of Shear Stress
The capillary network is comprised of the pre-capillary ar-
terioles, the capillary bed and the post-capillary venules, and 
furthermore is characterized by a high degree of structural 
heterogeneity as well as having a typically asymmetric and 
irregular distribution in the vasculature.
64) The microvascular 
topography and complexity varies in different organs, presum-
ably reflecting the different structural and functional features 
of specific tissues. The number of capillaries in the human 
body is extremely large and includes approximately 2×10
9 
capillaries.
64)65) 
Fig. 4 shows an illustrated reconstruction of the capillary 
portion of microvascular networks,
66) which shows vessel seg-
ments, nodes (branch points), the length and connectivity of 
each capillary segment up to capillary exits on the collecting 
venule. Capillary entrance (A) and exit (V) pressures were set 
to 20 mmHg and 10 mmHg, respectively.
66) Pries et al.
6) report-
ed an average pressure drop across capillaries of 9.1±6.1 
mmHg. Shea and Raskova
67) reported their observations of a 
murine kidney microvascular structure with the afferent ar-
teriole divided into five primary capillary segments similar 
to the structure shown in Fig. 4. They found the total capillary 
length in a range of 5-9 mm with a mean capillary segment le-
ngth of 33±23 μm with a pressure drop of 12 mmHg across 
the capillary network.
The length of capillaries varies widely from organ to organ. 
The path length by which blood traverses the capillaries may 
actually be longer than the actual measured distance because 
of extensive anastomoses in the capillary network.
68) In tissue 
regions with high metabolic demand such as in the retina and 
myocardium, the length of capillaries is relatively short but 
also with high capillary density, to better cope with tempo-
rarily insufficient or stagnating blood flow.
65)68) McManus et 
al.
68) measured the capillary length from terminal arteriole 
to collecting venule, which ranged from 0.1 to 3 mm with an av-
erage of 1 mm. Payman and Lyon
69) reported that an abso-
lute capillary length in murine utricular macula was 8.45± 
1.6 mm with a mean capillary diameter of 5.84±0.56 μm. In 
tissue with lower metabolic demand, the capillary is relatively 
long. For example, capillary lengths in skin capillary networks 
are 1-3 mm,
65) whereas they are several hundred microns in 
the peri-macular capillary network.
70) In particular, Lübbers and 
his co-workers
71)72) demonstrated using animal models that 
capillary lengths in the kidneys can be very long, i.e., 100-550 
mm.
65) Pries et al.
6) reported that the pressure gradient in mu-
rine mesentery capillaries was in the range of 0.1-0.5 mmHg/
mm. The wall shear stress at the capillary can be determined us-
ing the pressure gradient of 0.1 mmHg/mm,
6) as: 
τw=
0.1mmHg [                 ]·5 μm
=0.016 Pa=0.16 dyne (9)
4 · (1 mm) cm2
Determination of Yield Stress 
Using Casson Model
For the estimation of the yield stress, one can use the fol-
lowing constitutive equation called the Casson model:
33)73)
√τ = √τy  + √κγ
.
        (10)
where κ is a Casson model constant representing an asymp-
totic high shear viscosity and τy is the yield stress of blood. 
From the Casson model, one can derive the Casson viscosity 
equation as
μ= τ =κ+ τy +2
√
κ · τy (11) γ
. γ
. γ
.
Fig. 5 shows five typical blood viscosity curves as a function 
of shear rate with κ equal to 3.8 cP (38 mP), including a very 
low blood viscosity curve (bottom) and a very high blood vis-
cosity curve (top). The second curve from the bottom with 
open circular symbols represents the normal blood viscosity 
101000 Pa
760 mmHg
Fig. 4. Illustrated reconstruction of the capillary portion of micro-
vascular networks. Arteriole and venule segments were cropped 
out, and capillary entrance (A) and exit (V) pressures were set to 
20 mmHg and 10 mmHg, respectively.
66)
20 mmHg 10 mmHg
A
VYoung-Il Cho, et al.   293
curve.
3)8)10)11)13-19) The yield stress could be determined from 
curve fitting of the viscosity curves using the above Casson vis-
cosity equation. The calculated yield stress values are shown 
in Fig. 5. Note that the normal viscosity curve gave a yield st-
ress of 0.065 dyne/cm
2, in close agreement with previous st-
udies.
53-57) The dotted viscosity curve with a DBV of 300 mP at 
shear rate of 1 s
-1 gave a yield stress of 0.125 dyne/cm
2, wher-
eas the dashed viscosity curve with a DBV of 412 mP gave a 
yield stress of 0.2 dyne/cm
2. 
A hemodynamic diagnostic approach is proposed here, com-
paring the yield stress of a patient’s blood with the microvas-
cular shear stress which maintains perfusion: if the yield st-
ress of a patient’s blood exceeds the shear stress needed to ma-
intain capillary flow, then ischemia and capillary loss may be 
triggered. Fig. 6 provides a theoretical case study showing 
how reference ranges for DBV and yield stress could be used 
to predict microvascular disorders. Fig. 6 gives yield stress 
values calculated using the Casson model for a range of DBV 
at shear rates of both 1 and 5 s
-1, in solid and dashed lines, res-
pectively. In general, the yield stress increases as the DBV in-
creases. Using Pries’ animal model for the vessel geometry 
and pressure gradient in capillary flow
6) and the force balance 
equation for microvascular shear stress, the threshold value for 
microvascular wall shear stress is calculated to be 0.16 dyne/
cm
2, which would be the minimum shear stress necessary to 
maintain capillary flow and prevent spontaneous erythrocyte 
aggregation, in this example. A patient with a DBV greater 
than 400 mP at a shear rate of 1 s
-1 would experience yield st-
ress levels that approach 0.2 dyne/cm
2. In such a case, depict-
ed by the top rectangular box in Fig. 6, the shear forces are 
not large enough to prevent erythrocyte aggregation, poten-
tially resulting in local hemostasis and the eventual loss of the 
capillaries. Normal physiologic yield stress levels of less than 
0.08 dyne/cm
2 are depicted using the bottom rectangular box 
in Fig. 6.
Final Remarks
The present review attempted to explain the cause of the 
capillary (length) loss, a common clinical outcome of micro-
vascular disorders. Abnormally elevated DBV produces a co-
unter-acting resistance to the flow at microvessels, and the 
relationship between DBV and the yield stress of blood was 
presented. Flow in the microvascular network was quanti-
fied in terms of the wall shear stress (WSS) under normal phy-
siological conditions using the pressure gradient suggested 
by Pries et al.
6) resulting in a calculated WSS threshold of 0.16 
dyne/cm
2 based on these assumptions. The present review 
proposed that when the yield stress is greater than the WSS, 
the flow at microvessels will stop, resulting in the capillary loss. 
The validity of the concept should be examined through cli-
nical studies. For example, the myocardium perfusion can be 
determined using adenosine-stress dual-energy CT or MRI 
measurement, and the correlation between the myocardium 
perfusion and elevated DBV can be studied. Furthermore, the 
Casson viscosity equation was used to estimate the yield st-
ress using a blood viscosity profile. Although the Casson equ-
ation is the most widely used model for blood viscosity, the 
use of a different model such as Herschel-Bulkley
73) could give 
a different value for the yield stress. These competing mod-
els should also be compared through clinical trials. 
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